Our top pick for
Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
BioDelivery Sciences International Inc is a drug manufacturers-specialty & generic business based in the US. BioDelivery Sciences International shares (BDSI) are listed on the NASDAQ and all prices are listed in US Dollars. BioDelivery Sciences International employs 200 staff and has a trailing 12-month revenue of around $166.7 million.
|Latest market close||$5.59|
|52-week range||$2.50 - $5.62|
|50-day moving average||$4.96|
|200-day moving average||$3.88|
|Wall St. target price||$5.38|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.82|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2022-09-16)||N/A|
|1 month (2022-08-23)||N/A|
|3 months (2022-06-23)||N/A|
|6 months (2022-03-23)||N/A|
|1 year (2021-09-27)||49.47%|
|2 years (2020-09-25)||48.28%|
|3 years (2019-09-27)||30.00%|
|5 years (2017-09-27)||92.76%|
Valuing BioDelivery Sciences International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of BioDelivery Sciences International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
BioDelivery Sciences International's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, BioDelivery Sciences International shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
BioDelivery Sciences International's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.95. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into BioDelivery Sciences International's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
BioDelivery Sciences International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $44.5 million.
The EBITDA is a measure of a BioDelivery Sciences International's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$166.7 million|
|Operating margin TTM||22.27%|
|Gross profit TTM||$143.3 million|
|Return on assets TTM||8.22%|
|Return on equity TTM||57.33%|
|Market capitalisation||$577.1 million|
TTM: trailing 12 months
We're not expecting BioDelivery Sciences International to pay a dividend over the next 12 months.
Over the last 12 months, BioDelivery Sciences International's shares have ranged in value from as little as $2.5 up to $5.62. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BioDelivery Sciences International's is 0.5551. This would suggest that BioDelivery Sciences International's shares are less volatile than average (for this exchange).
BioDelivery Sciences International, Inc. , a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; and Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. The company also provides ELYXYB, a celecoxib oral solution for the treatment of migraine with or without aura in adults; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.